Cargando…

Gray matter volume reduction with different disease duration in trigeminal neuralgia

PURPOSE: Structural magnetic resonance imaging is widely used to explore brain gray and white matter structure in trigeminal neuralgia (TN) but has yielded conflicting findings. This study investigated the relationship between disease duration as a clinical feature of TN and changes in brain structu...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Shanshan, Zheng, Huifeng, Wang, Jianwei, Guo, Wenchang, Guo, Xiaowan, Ji, Hong, Zhang, Shuqian, Chen, Yingmin, Shi, Gaofeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397610/
https://www.ncbi.nlm.nih.gov/pubmed/34453181
http://dx.doi.org/10.1007/s00234-021-02783-y
_version_ 1783744653907984384
author Shen, Shanshan
Zheng, Huifeng
Wang, Jianwei
Guo, Wenchang
Guo, Xiaowan
Ji, Hong
Zhang, Shuqian
Chen, Yingmin
Shi, Gaofeng
author_facet Shen, Shanshan
Zheng, Huifeng
Wang, Jianwei
Guo, Wenchang
Guo, Xiaowan
Ji, Hong
Zhang, Shuqian
Chen, Yingmin
Shi, Gaofeng
author_sort Shen, Shanshan
collection PubMed
description PURPOSE: Structural magnetic resonance imaging is widely used to explore brain gray and white matter structure in trigeminal neuralgia (TN) but has yielded conflicting findings. This study investigated the relationship between disease duration as a clinical feature of TN and changes in brain structure. METHODS: We divided 49 TN patients into three groups (TN1–TN3) based on disease duration (TN1 = 1.1 ± 0.7 (0–2) years, TN2 = 4.8 ± 1.5 (3–7) years, TN3 = 15.1 ± 5.5 (10–30) years). We used voxel-based morphometry (VBM) to compare the gray matter volume (GMV) across groups and between TN patients and 18 matched healthy control subjects. RESULTS: The TN1 group showed reduced GMV of pain-related regions in the cerebellum; the TN2 group showed reduced GMV in the thalamus and the motor/sensory cortex; and the TN3 group showed reduced GMV in the emotional and reward circuits compared with healthy controls. Similar brain regions, including bilateral hippocampi, caudate, left insular cortex, and medial superior frontal cortex, were affected in TN2 and TN3 compared with TN1. CONCLUSION: Disease duration can explain differences in structural alterations—especially in pain-related brain regions—in TN. These results highlight the advanced structural neuroimaging method that are valuable tools to assess the trigeminal system in TN and may further our current understanding of TN pathology.
format Online
Article
Text
id pubmed-8397610
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-83976102021-08-30 Gray matter volume reduction with different disease duration in trigeminal neuralgia Shen, Shanshan Zheng, Huifeng Wang, Jianwei Guo, Wenchang Guo, Xiaowan Ji, Hong Zhang, Shuqian Chen, Yingmin Shi, Gaofeng Neuroradiology Functional Neuroradiology PURPOSE: Structural magnetic resonance imaging is widely used to explore brain gray and white matter structure in trigeminal neuralgia (TN) but has yielded conflicting findings. This study investigated the relationship between disease duration as a clinical feature of TN and changes in brain structure. METHODS: We divided 49 TN patients into three groups (TN1–TN3) based on disease duration (TN1 = 1.1 ± 0.7 (0–2) years, TN2 = 4.8 ± 1.5 (3–7) years, TN3 = 15.1 ± 5.5 (10–30) years). We used voxel-based morphometry (VBM) to compare the gray matter volume (GMV) across groups and between TN patients and 18 matched healthy control subjects. RESULTS: The TN1 group showed reduced GMV of pain-related regions in the cerebellum; the TN2 group showed reduced GMV in the thalamus and the motor/sensory cortex; and the TN3 group showed reduced GMV in the emotional and reward circuits compared with healthy controls. Similar brain regions, including bilateral hippocampi, caudate, left insular cortex, and medial superior frontal cortex, were affected in TN2 and TN3 compared with TN1. CONCLUSION: Disease duration can explain differences in structural alterations—especially in pain-related brain regions—in TN. These results highlight the advanced structural neuroimaging method that are valuable tools to assess the trigeminal system in TN and may further our current understanding of TN pathology. Springer Berlin Heidelberg 2021-08-28 2022 /pmc/articles/PMC8397610/ /pubmed/34453181 http://dx.doi.org/10.1007/s00234-021-02783-y Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021, corrected publication 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Functional Neuroradiology
Shen, Shanshan
Zheng, Huifeng
Wang, Jianwei
Guo, Wenchang
Guo, Xiaowan
Ji, Hong
Zhang, Shuqian
Chen, Yingmin
Shi, Gaofeng
Gray matter volume reduction with different disease duration in trigeminal neuralgia
title Gray matter volume reduction with different disease duration in trigeminal neuralgia
title_full Gray matter volume reduction with different disease duration in trigeminal neuralgia
title_fullStr Gray matter volume reduction with different disease duration in trigeminal neuralgia
title_full_unstemmed Gray matter volume reduction with different disease duration in trigeminal neuralgia
title_short Gray matter volume reduction with different disease duration in trigeminal neuralgia
title_sort gray matter volume reduction with different disease duration in trigeminal neuralgia
topic Functional Neuroradiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397610/
https://www.ncbi.nlm.nih.gov/pubmed/34453181
http://dx.doi.org/10.1007/s00234-021-02783-y
work_keys_str_mv AT shenshanshan graymattervolumereductionwithdifferentdiseasedurationintrigeminalneuralgia
AT zhenghuifeng graymattervolumereductionwithdifferentdiseasedurationintrigeminalneuralgia
AT wangjianwei graymattervolumereductionwithdifferentdiseasedurationintrigeminalneuralgia
AT guowenchang graymattervolumereductionwithdifferentdiseasedurationintrigeminalneuralgia
AT guoxiaowan graymattervolumereductionwithdifferentdiseasedurationintrigeminalneuralgia
AT jihong graymattervolumereductionwithdifferentdiseasedurationintrigeminalneuralgia
AT zhangshuqian graymattervolumereductionwithdifferentdiseasedurationintrigeminalneuralgia
AT chenyingmin graymattervolumereductionwithdifferentdiseasedurationintrigeminalneuralgia
AT shigaofeng graymattervolumereductionwithdifferentdiseasedurationintrigeminalneuralgia